Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.

MedStar author(s):
Citation: Journal of Thrombosis & Thrombolysis. 43(2):166-171, 2017 FebPMID: 27696084Institution: MedStar Washington Hospital CenterDepartment: Hematology/OncologyForm of publication: Journal ArticleMedline article type(s): Journal Article | Validation StudiesSubject headings: *Neoplasms/co [Complications] | *Rivaroxaban/tu [Therapeutic Use] | *Venous Thromboembolism/dt [Drug Therapy] | Anticoagulants/tu [Therapeutic Use] | Cohort Studies | Female | Hemorrhage/ci [Chemically Induced] | Humans | Male | Middle Aged | Neoplasms/dt [Drug Therapy] | Prospective Studies | Recurrence | Rivaroxaban/st [Standards] | Treatment Outcome | Venous Thromboembolism/et [Etiology]Year: 2017ISSN:
  • 0929-5305
Name of journal: Journal of thrombosis and thrombolysisAll authors: Brar G, Harnicar S, Laube E, Mantha S, Miao Y, Parameswaran R, Samedy P, Sarasohn DM, Soff GA, Stefanik S, Wills JFiscal year: FY2017 Digital Object Identifier: Date added to catalog: 2017-05-06
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 27696084 Available 27696084

English

Powered by Koha